Inflammation response of epithelial mucosa to chemo-radiotherapy cytotoxic effects leads to
mucositis, a painful side effect of antineoplastic treatments. About 40% of the patients treated …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer
worldwide. It accounts for 2.5% of all new cancer cases and 1.9% of all cancer deaths …

Mucositis is a common complication of chemotherapy, radiotherapy and targeted agents. It
often affects compliance to anticancer therapies as it frequently causes schedule delays …

Background: Chemoradiotherapy-associated mucositis can manifest as pain, inflammation,
dysphagia, diarrhea, weight loss, rectal bleeding, and infection. Mucositis is a major dose …

Background Considerable progress has been made in our understanding of the biological
basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of …

PURPOSE: To explore the relationship between oral mucositis and selected clinical and
economic outcomes in blood and marrow transplant patients. PATIENTS AND METHODS …

Ionising radiation therapy is a common treatment modality for different types of cancer and
its use is expected to increase with advances in screening and early detection of cancer …

Mucositis and xerostomia are the most common oral complications of the non‐surgical
therapy of cancer. Mucositis, a common sequel of radio‐(DXR), chemo‐(CXR) and …

Oral mucosal drug delivery systems have been developed to expedite the regeneration of
oral mucosa, there are still many challenges related to residence time for drugs because the …

Background Oral mucositis (OM) due to radiotherapy and systemic therapies in head and
neck cancer treatment represents a major problem causing a wide spectrum of clinical signs …